Related references
Note: Only part of the references are listed.Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome Results From a Prospective, Single-Center, Clinicopathologic Case Series
Sigurd F. Lax et al.
ANNALS OF INTERNAL MEDICINE (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China Prevalence, Risk Factors, and Outcome
Li Zhang et al.
CIRCULATION (2020)
Pulmonary Embolism in Patients With COVID-19 Awareness of an Increased Prevalence
Julien Poissy et al.
CIRCULATION (2020)
Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?
Maarten Criel et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis
Giuseppe Lippi et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Deepa R. J. Arachchillage et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Jean-Francois Llitjos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Incidence of venous thromboembolism in hospitalized patients with COVID-19
Saskia Middeldorp et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
Giuseppe Lippi et al.
CLINICA CHIMICA ACTA (2020)
Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
F. Galeano-Valle et al.
THROMBOSIS RESEARCH (2020)
Severe COVID-19 infection associated with endothelial activation
Robert Escher et al.
THROMBOSIS RESEARCH (2020)
Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels
P. Demelo-Rodriguez et al.
THROMBOSIS RESEARCH (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
Laboratory Diagnostics in Thrombophilia
Birgit Linnemann et al.
HAMOSTASEOLOGIE (2019)
Dalteparin versus Unfractionated Heparin in Critically Ill Patients
Deborah Cook et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)